CAPTRUST Financial Advisors
ANIP icon

CAPTRUST Financial Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,904
Closed -$459K – 2663
2023
Q3 		$459K Buy
7,904
+60
+0.8% +$3.46K ﹤0.01% 1699
2023
Q2 		$422K Buy
+7,844
New +$348K ﹤0.01% 1715
2022
Q3 		– Sell
-640
Closed -$19K – 2155
2022
Q2 		$19K Buy
640
+108
+20% +$3.12K ﹤0.01% 3396
2022
Q1 		$15K Buy
532
+467
+718% +$17.4K ﹤0.01% 3564
2021
Q4 		$3K Buy
65
+17
+35% +$730 ﹤0.01% 4254
2021
Q3 		$2K Buy
48
+19
+66% +$591 ﹤0.01% 4229
2021
Q2 		$1K Sell
29
-20
-41% -$680 ﹤0.01% 4298
2021
Q1 		$2K Buy
49
+29
+145% +$908 ﹤0.01% 4007
2020
Q4 		$1K Buy
20
+3
+18% +$86 ﹤0.01% 3220
2020
Q3 		$0 Hold
17
– – ﹤0.01% 3042
2020
Q2 		$1K Buy
+17
New +$610 ﹤0.01% 2682
2019
Q4 		– Sell
-17
Closed -$1K – 1040
2019
Q3 		$1K Hold
17
– – ﹤0.01% 1845
2019
Q2 		$1K Hold
17
– – ﹤0.01% 1848
2019
Q1 		$1K Buy
+17
New +$1K ﹤0.01% 1728

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's ANIP Position: Q4 2023 in Review

CAPTRUST Financial Advisors sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 7,904 shares — an estimated $459K sold.

CAPTRUST Financial Advisors first reported a position in ANIP in Q1 2019 and held it in 14 quarters. The position peaked at $459K in Q3 2023. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • CAPTRUST Financial Advisors reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 7,904 ANI Pharmaceuticals shares in Q4 2023, an estimated $459K.
  • CAPTRUST Financial Advisors first reported a position in ANI Pharmaceuticals in Q1 2019 and held it in 14 quarters.
  • CAPTRUST Financial Advisors's ANI Pharmaceuticals position peaked at $459K in Q3 2023.
  • 181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.